Clinical Trial Update: PD-1 Inhibitor Based Induction Chemotherapy Followed by De-escalation Protocols in OPSCC [Phase 2]

View source ↗

Summary

Phase 2 trial update on PD-1 inhibitor–based induction chemotherapy followed by de-escalation in oropharyngeal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oropharyngeal Cancer

Drugs mentioned

• PD-1 inhibitor

Snippet

Sponsor: Fudan University | Conditions: Oropharyngeal Cancer | Phase 2 | Status: UNKNOWN